abstract |
A fused bicyclic indole, indoline, azoindole, or azoindoline compound of Formula 1 is provided. Also disclosed are pharmaceutically acceptable salts of these compounds and pharmaceutical compositions comprising these compounds. In addition, methods of treating cancers such as glioma, prostate cancer, and colorectal cancer with these compounds are also disclosed. |